ただし、追加料金で日本語のレポートが入手できる場合もある。
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Japan Insulin Drugs Delivery Devices Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Japan Insulin Drugs Delivery Devices Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)
6 Japan Insulin Drugs Delivery Devices Market - Breakup by Type
6.1 Drug
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.3.1 Basal or Long-Acting Insulins
6.1.3.1.1 Lantus (Insulin Glargine)
6.1.3.1.2 Levemir (Insulin Detemir)
6.1.3.1.3 Toujeo (Insulin Glargine)
6.1.3.1.4 Tresiba (Insulin Degludec)
6.1.3.1.5 Basaglar (Insulin Glargine)
6.1.3.2 Bolus or Fast-Acting Insulins
6.1.3.2.1 NovoRapid/Novolog (Insulin Aspart)
6.1.3.2.2 Humalog (Insulin lispro)
6.1.3.2.3 Apidra (Insulin Glulisine)
6.1.3.2.4 FIASP (Insulin Aspart)
6.1.3.2.5 Admelog (Insulin lispro Sanofi)
6.1.3.3 Traditional Human Insulins
6.1.3.3.1 Novolin/Mixtard/Actrapid/Insulatard
6.1.3.3.2 Humulin
6.1.3.3.3 Insuman
6.1.3.4 Combination Insulins
6.1.3.4.1 NovoMix (Biphasic Insulin aspart)
6.1.3.4.2 Ryzodeg (Insulin Degludec and Insulin aspart)
6.1.3.4.3 Xultophy (Insulin Degludec and Liraglutide)
6.1.3.4.4 Soliqua/Suliqua (Insulin Glargine and Lixisenatide)
6.1.3.5 Biosimilar Insulins
6.1.3.5.1 Insulin Glargine Biosimilars
6.1.3.5.2 Human Insulin Biosimilars
6.1.4 Market Forecast (2025-2033)
6.2 Device
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.3.1 Insulin Pumps
6.2.3.1.1 Insulin Pump Devices
6.2.3.1.2 Insulin Pump Reservoirs
6.2.3.1.3 Insulin Infusion Sets
6.2.3.2 Insulin Pens
6.2.3.2.1 Cartridges in Reusable Pens
6.2.3.2.2 Disposable Insulin Pens
6.2.3.3 Insulin Syringes
6.2.3.4 Insulin Jet Injectors
6.2.4 Market Forecast (2025-2033)
7 Japan Insulin Drugs Delivery Devices Market – Breakup by Region
7.1 Kanto Region
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Breakup by Type
7.1.4 Key Players
7.1.5 Market Forecast (2025-2033)
7.2 Kansai/Kinki Region
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Breakup by Type
7.2.4 Key Players
7.2.5 Market Forecast (2025-2033)
7.3 Central/ Chubu Region
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2019-2024)
7.3.3 Market Breakup by Type
7.3.4 Key Players
7.3.5 Market Forecast (2025-2033)
7.4 Kyushu-Okinawa Region
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2019-2024)
7.4.3 Market Breakup by Type
7.4.4 Key Players
7.4.5 Market Forecast (2025-2033)
7.5 Tohoku Region
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2019-2024)
7.5.3 Market Breakup by Type
7.5.4 Key Players
7.5.5 Market Forecast (2025-2033)
7.6 Chugoku Region
7.6.1 Overview
7.6.2 Historical and Current Market Trends (2019-2024)
7.6.3 Market Breakup by Type
7.6.4 Key Players
7.6.5 Market Forecast (2025-2033)
7.7 Hokkaido Region
7.7.1 Overview
7.7.2 Historical and Current Market Trends (2019-2024)
7.7.3 Market Breakup by Type
7.7.4 Key Players
7.7.5 Market Forecast (2025-2033)
7.8 Shikoku Region
7.8.1 Overview
7.8.2 Historical and Current Market Trends (2019-2024)
7.8.3 Market Breakup by Type
7.8.4 Key Players
7.8.5 Market Forecast (2025-2033)
8 Japan Insulin Drugs Delivery Devices Market – Competitive Landscape
8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant
9 Profiles of Key Players
9.1 Company A
9.1.1 Business Overview
9.1.2 Product Portfolio
9.1.3 Business Strategies
9.1.4 SWOT Analysis
9.1.5 Major News and Events
9.2 Company B
9.2.1 Business Overview
9.2.2 Product Portfolio
9.2.3 Business Strategies
9.2.4 SWOT Analysis
9.2.5 Major News and Events
9.3 Company C
9.3.1 Business Overview
9.3.2 Product Portfolio
9.3.3 Business Strategies
9.3.4 SWOT Analysis
9.3.5 Major News and Events
9.4 Company D
9.4.1 Business Overview
9.4.2 Product Portfolio
9.4.3 Business Strategies
9.4.4 SWOT Analysis
9.4.5 Major News and Events
9.5 Company E
9.5.1 Business Overview
9.5.2 Product Portfolio
9.5.3 Business Strategies
9.5.4 SWOT Analysis
9.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.
10 Japan Insulin Drugs Delivery Devices Market - Industry Analysis
10.1 Drivers, Restraints, and Opportunities
10.1.1 Overview
10.1.2 Drivers
10.1.3 Restraints
10.1.4 Opportunities
10.2 Porters Five Forces Analysis
10.2.1 Overview
10.2.2 Bargaining Power of Buyers
10.2.3 Bargaining Power of Suppliers
10.2.4 Degree of Competition
10.2.5 Threat of New Entrants
10.2.6 Threat of Substitutes
10.3 Value Chain Analysis
11 Appendix